COMPANY
ALLSINO PHARMACEUTICAL CO LTD
ALLSINO PHARMACEUTICAL CO LTD: API manufacturer for Semaglutide, Tirzepatide, as stated by public registers.
API MANUFACTURER
Filed a drug master file with FDA for the active ingredient.
| Semaglutide | DMF 41509, type II, active, submitted 2025-03-18 Regulator FDA drug master file list |
|---|---|
| Semaglutide | DMF 41510, type II, active, submitted 2025-03-18 Regulator FDA drug master file list |
| Semaglutide | DMF 41511, type II, active, submitted 2025-03-18 Regulator FDA drug master file list |
| Tirzepatide | DMF 42448, type II, active, submitted 2025-08-22 Regulator FDA drug master file list |
| Tirzepatide | DMF 42449, type II, active, submitted 2025-09-28 Regulator FDA drug master file list |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.